Ramucirumab plus docetaxel after combination chemoimmunotherapy in patients with non-small cell lung cancer: A prospective observational study

被引：0
|
作者：
Yamada, T. [1 ]
Katayama, Y. [2 ]
Watanabe, S. [3 ]
Watanabe, K. [4 ]
Takeda, T. [5 ]
Chihara, Y. [6 ]
Shiotsu, S. [7 ]
Hibino, M. [8 ]
Harada, T. [9 ]
Takayama, K. [1 ]
机构：
[1] Kyoto Prefectural Univ Med, Pulm Med, Kyoto, Japan
[2] Kyoto Prefectural Univ Med, Resp, Kyoto, Japan
[3] Niigata Univ Med & Dent Hosp, Dept Resp Med & Infect Dis, Niigata, Japan
[4] Tokyo Metropolitan Canc & Infect Dis Ctr Komagome, Thorac Oncol & Resp Med Dept, Bunkyo Ku, Tokyo, Japan
[5] Japanese Red Cross Kyoto Daini Hosp, Resp Med, Kyoto, Japan
[6] Uji Tokushukai Med Ctr, Resp Med, Uji, Japan
[7] Kyoto First Red Cross Hosp Kyoto Daiichi Sekijyuj, Oncol, Kyoto, Japan
[8] Shonan Fujisawa Tokushukai Hosp, Resp Med, Fujisawa, Kanagawa, Japan
[9] Fukuchiyama City Hosp, Med Oncol, Fukuchiyama, Japan
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.10.608
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
529P
引用
收藏
页码：S1676 / S1676
页数：1
相关论文
共 50 条
  • [1] Prospective Observational Study of Ramucirumab Plus Docetaxel After Combined Chemoimmunotherapy in Patients With Non-Small-Cell Lung Cancer
    Katayama, Yuki
    Yamada, Tadaaki
    Sawada, Ryo
    Kawachi, Hayato
    Morimoto, Kenji
    Watanabe, Satoshi
    Watanabe, Kageaki
    Takeda, Takayuki
    Chihara, Yusuke
    Shiotsu, Shinsuke
    Hibino, Makoto
    Harada, Taishi
    Nishioka, Naoya
    Iwasaku, Masahiro
    Tokuda, Shinsaku
    Takayama, Koichi
    ONCOLOGIST, 2024, : e681 - e689
  • [2] Impact of docetaxel plus ramucirumab in a second-line setting after chemoimmunotherapy in patients with non-small-cell lung cancer: A retrospective study
    Ishida, Masaki
    Morimoto, Kenji
    Yamada, Tadaaki
    Shiotsu, Shinsuke
    Chihara, Yusuke
    Yamada, Takahiro
    Hiranuma, Osamu
    Morimoto, Yoshie
    Iwasaku, Masahiro
    Tokuda, Shinsaku
    Takeda, Takayuki
    Takayama, Koichi
    THORACIC CANCER, 2022, 13 (02) : 173 - 181
  • [3] The efficacy and safety of ramucirumab plus docetaxel in older patients with advanced non-small cell lung cancer
    Sakaguchi, Tadashi
    Furuya, Naoki
    Ito, Kentaro
    Hida, Naoya
    Morikawa, Kei
    Komase, Yuko
    Inoue, Takeo
    Hataji, Osamu
    Mineshita, Masamichi
    THORACIC CANCER, 2020, 11 (06) : 1559 - 1565
  • [4] Effectiveness of Ramucirumab Plus Docetaxel for Advanced Non-Small Cell Lung Cancer Patients: a Cohort of 93 Patients
    Barcelos, Isabella Favato
    De Marchi, Pedro
    Aguiar Junior, Pedro Nazareth
    Montella, Tatiane Caldas
    Afonso, Nathalia Gimenes
    Visani, Filipe
    Negreiros, Izabella Santos
    De Cerqueira Mathias, Clarissa Maria
    Paes, Rafael Duarte
    Dienstmann, Rodrigo
    Ferreira, Carlos Gil
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (03) : S13 - S13
  • [5] Retrospective analysis of docetaxel in combination with ramucirumab for previously treated non-small cell lung cancer patients
    Kitadai, Rui
    Yoshimura, Akihiro
    Yamada, Tadaaki
    Okuma, Yusuke
    Takeda, Takayuki
    Kanematsu, Takanori
    Uchino, Junji
    Nishioka, Yasuhiko
    Takayama, Koichi
    CANCER RESEARCH, 2020, 80 (16)
  • [6] Retrospective analysis of docetaxel in combination with ramucirumab for previously treated non-small cell lung cancer patients
    Yoshimura, Akihiro
    Yamada, Tadaaki
    Okuma, Yusuke
    Kitadai, Rui
    Takeda, Takayuki
    Kanematsu, Takanori
    Goto, Hisatsugu
    Yoneda, Hiroto
    Harada, Taishi
    Kubota, Yutaka
    Yamada, Takahiro
    Date, Koji
    Shiotsu, Shinsuke
    Nagata, Kazuhiro
    Chihara, Yusuke
    Kaneko, Yoshiko
    Uchino, Junji
    Nishioka, Yasuhiko
    Takayama, Koichi
    TRANSLATIONAL LUNG CANCER RESEARCH, 2019, 8 (04) : 450 - +
  • [7] Improved efficacy of ramucirumab plus docetaxel after nivolumab failure in previously treated non-small cell lung cancer patients
    Shiono, Ayako
    Kaira, Kyoichi
    Mouri, Atsuto
    Yamaguchi, Ou
    Hashimoto, Kosuke
    Uchida, Takahiro
    Miura, Yu
    Nishihara, Fuyumi
    Murayama, Yoshitake
    Kobayashi, Kunihiko
    Kagamu, Hiroshi
    THORACIC CANCER, 2019, 10 (04) : 775 - 781
  • [8] Impact of ramucirumab pharmacokinetics in combination with docetaxel on the efficacy and survival in patients with advanced non-small cell lung cancer
    Akagi, Kazumasa
    Yagishita, Shigehiro
    Ohuchi, Mayu
    Hayashi, Yoshiharu
    Takeyasu, Yuki
    Masuda, Ken
    Shinno, Yuki
    Okuma, Yusuke
    Yoshida, Tatsuya
    Goto, Yasushi
    Horinouchi, Hidehito
    Yamamoto, Noboru
    Mukae, Hiroshi
    Ohe, Yuichiro
    Hamada, Akinobu
    LUNG CANCER, 2023, 178 : 247 - 253
  • [9] Clinical outcomes of ramucirumab plus docetaxel in the treatment of patients with non-small cell lung cancer after immunotherapy: a systematic literature review
    Garon, Edward B.
    Visseren-Grul, Carla
    Rizzo, Maria Teresa
    Puri, Tarun
    Chenji, Suresh
    Reck, Martin
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [10] Efficacy of subsequent docetaxel plus /- ramucirumab and S-1 after nivolumab for patients with advanced non-small cell lung cancer
    Tamura, Nobumasa
    Horinouchi, Hidehito
    Sekine, Katsutoshi
    Matsumoto, Yuji
    Murakami, Shuji
    Goto, Yasushi
    Kanda, Shintaro
    Fujiwara, Yutaka
    Yamamoto, Noboru
    Ohe, Yuichiro
    THORACIC CANCER, 2019, 10 (05) : 1141 - 1148
12345